Crosstalk between RNA m

N6-methyladenosine cancer circular RNA long non-coding RNA microRNA non-coding RNA

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
08 Aug 2020
Historique:
received: 16 05 2020
revised: 04 06 2020
accepted: 07 08 2020
pubmed: 11 9 2020
medline: 11 9 2020
entrez: 10 9 2020
Statut: aheadofprint

Résumé

N6-methyladenosine (m

Identifiants

DOI: 10.1016/j.omtn.2020.08.004 PMID: 32911345 PMC: PMC7486578
pubmed: 32911345
pii: S2162-2531(20)30233-X
doi: 10.1016/j.omtn.2020.08.004
pmc: PMC7486578
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

62-71

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Cell Death Dis. 2018 Jan 26;9(2):124
pubmed: 29374143
Cell Res. 2018 May;28(5):507-517
pubmed: 29686311
Anal Chem. 2016 Jan 19;88(2):1378-84
pubmed: 26707930
Proc Natl Acad Sci U S A. 1974 Oct;71(10):3971-5
pubmed: 4372599
Nature. 1986 Oct 9-15;323(6088):558-60
pubmed: 2429192
Mol Ther Nucleic Acids. 2019 Jun 7;16:589-596
pubmed: 31082792
Annu Rev Cell Dev Biol. 2017 Oct 6;33:319-342
pubmed: 28759256
Cancer Cell. 2020 Mar 16;37(3):270-288
pubmed: 32183948
Nat Rev Genet. 2014 Jan;15(1):7-21
pubmed: 24296535
J Biol Chem. 2017 Mar 3;292(9):3614-3623
pubmed: 28104805
Gastroenterology. 2019 Feb;156(3):676-691.e11
pubmed: 30445010
Nucleic Acids Res. 2018 May 4;46(8):3906-3920
pubmed: 29529255
Front Genet. 2020 Apr 23;11:306
pubmed: 32391046
BMC Cancer. 2016 Sep 01;16:706
pubmed: 27586393
Nat Rev Drug Discov. 2017 Mar;16(3):203-222
pubmed: 28209991
Mol Cancer. 2020 Jun 2;19(1):99
pubmed: 32487167
Cell Rep. 2017 Aug 29;20(9):2262-2276
pubmed: 28854373
Nat Commun. 2019 Apr 23;10(1):1858
pubmed: 31015415
Mol Cancer. 2019 Apr 18;18(1):90
pubmed: 30999909
Nat Commun. 2019 Oct 16;10(1):4695
pubmed: 31619685
Nature. 1979 Jul 26;280(5720):339-40
pubmed: 460409
Aging Cell. 2018 Jun;17(3):e12753
pubmed: 29573145
Cell. 2017 May 18;169(5):824-835.e14
pubmed: 28525753
Cell Res. 2018 Nov;28(11):1062-1076
pubmed: 30297871
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Cancer Res. 2019 Apr 1;79(7):1285-1292
pubmed: 30894375
Nucleic Acids Res. 2018 Jun 1;46(10):5195-5208
pubmed: 29506078
Cell Death Dis. 2018 Jul 23;9(8):796
pubmed: 30038300
Cancer Manag Res. 2019 Feb 01;11:1177-1187
pubmed: 30774445
Cell. 2014 Aug 28;158(5):980-987
pubmed: 25171402
Cancer Res. 2019 Sep 15;79(18):4612-4626
pubmed: 31331909
Cell Metab. 2019 Jul 2;30(1):157-173.e7
pubmed: 31155494
Mol Cancer. 2019 Dec 2;18(1):174
pubmed: 31791342
Cancer Cell Int. 2019 Dec 2;19:321
pubmed: 31827395
Nat Rev Mol Cell Biol. 2017 Jan;18(1):31-42
pubmed: 27808276
Nucleic Acids Res. 2015 Jan;43(1):373-84
pubmed: 25452335
Cell Res. 2014 Feb;24(2):177-89
pubmed: 24407421
Cancer Res. 2018 Sep 1;78(17):4812-4825
pubmed: 29967262
Physiol Rev. 2016 Oct;96(4):1297-325
pubmed: 27535639
Cancer Lett. 2018 Feb 28;415:11-19
pubmed: 29174803
Eur Urol. 2019 Sep;76(3):315-326
pubmed: 30527798
Mol Cancer. 2019 Dec 10;18(1):181
pubmed: 31823788
Int J Cancer. 2020 Feb 15;146(4):906-916
pubmed: 30873588
Cell. 2015 Sep 10;162(6):1299-308
pubmed: 26321680
Front Oncol. 2020 Mar 09;10:208
pubmed: 32211315
Parkinsonism Relat Disord. 2018 Aug;53:46-52
pubmed: 29759929
Cell Res. 2017 May;27(5):626-641
pubmed: 28281539
Cancer Cell Int. 2020 Jan 30;20:34
pubmed: 32021563
Cell Physiol Biochem. 2018;48(2):838-846
pubmed: 30032148
Chem Biol. 2015 Feb 19;22(2):262-72
pubmed: 25641166
Annu Rev Biochem. 2010;79:351-79
pubmed: 20533884
Int J Mol Sci. 2018 Aug 09;19(8):
pubmed: 30096915
Mol Cancer. 2019 Apr 13;18(1):87
pubmed: 30979372
Mol Cancer. 2017 May 23;16(1):94
pubmed: 28535767
Nat Chem Biol. 2011 Oct 16;7(12):885-7
pubmed: 22002720
Cancer Cell. 2017 Apr 10;31(4):591-606.e6
pubmed: 28344040
Nucleic Acids Res. 2019 Jan 10;47(1):375-390
pubmed: 30371874
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Mol Cancer. 2019 Oct 16;18(1):143
pubmed: 31619268
Mol Cell. 2013 Jan 10;49(1):18-29
pubmed: 23177736
Clin Chem. 2020 Feb 1;66(2):342-351
pubmed: 32040577
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9
pubmed: 12434020
Cell Death Differ. 2020 Jun;27(6):1782-1794
pubmed: 31804607
Biol Psychiatry. 2020 Sep 1;88(5):392-404
pubmed: 32387133
Mol Cancer. 2019 Jun 22;18(1):110
pubmed: 31228940
Mol Cancer. 2019 Mar 28;18(1):46
pubmed: 30922314
Cell. 2012 Jun 22;149(7):1635-46
pubmed: 22608085
Mol Cancer. 2020 Feb 28;19(1):44
pubmed: 32111216
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Front Cell Dev Biol. 2019 Jun 28;7:116
pubmed: 31316981
Cell. 2018 Jan 25;172(3):393-407
pubmed: 29373828
Int J Biol Sci. 2020 Mar 25;16(11):1785-1797
pubmed: 32398949
Hepatology. 2017 Feb;65(2):529-543
pubmed: 27774652
Cancer Cell Int. 2020 May 7;20:157
pubmed: 32419773
Biochem Biophys Res Commun. 2017 Jan 22;482(4):582-589
pubmed: 27856248
Nature. 2011 May 19;473(7347):337-42
pubmed: 21593866
Cell Rep. 2020 May 12;31(6):107641
pubmed: 32402287
J Exp Clin Cancer Res. 2019 Sep 6;38(1):393
pubmed: 31492150
FEBS Lett. 2016 Jun;590(11):1641-50
pubmed: 27153315
Cell Rep. 2017 Mar 14;18(11):2622-2634
pubmed: 28297667
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Nature. 2015 Mar 26;519(7544):482-5
pubmed: 25799998
Cancer Cell. 2015 Mar 9;27(3):370-81
pubmed: 25759022
J Hepatol. 2016 Jun;64(6):1283-94
pubmed: 26812074
Nat Commun. 2020 Apr 3;11(1):1685
pubmed: 32245947
J Physiol Biochem. 2019 Aug;75(3):379-389
pubmed: 31290116
J Hematol Oncol. 2020 Jan 8;13(1):5
pubmed: 31915027
Cancer Res. 2019 Apr 1;79(7):1398-1412
pubmed: 30563888

Auteurs

Fengsheng Dai (F)

Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China; Department of Otolaryngology Head & Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China.

Yongyan Wu (Y)

Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China; Shanxi Province Clinical Medical Research Center for Precision Medicine of Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China; Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, P. R. China. Electronic address: wuyongyan@sxent.org.

Yan Lu (Y)

Department of Otolaryngology Head & Neck Surgery, The First Hospital of Jinzhou Medical University, Jinzhou 121001, P. R. China.

Changming An (C)

Department of Head and Neck Surgery, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, P. R. China.

Xiwang Zheng (X)

Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China; Shanxi Province Clinical Medical Research Center for Precision Medicine of Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China.

Li Dai (L)

Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China; Department of Otolaryngology Head & Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China.

Yujia Guo (Y)

Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China; Shanxi Province Clinical Medical Research Center for Precision Medicine of Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China.

Linshi Zhang (L)

Department of Thyroid Surgery, Second Affiliated Hospital of Zhejiang University, Hangzhou 310009, P. R. China.

Huizheng Li (H)

Department of Otolaryngology Head & Neck Surgery, Dalian Municipal Friendship Hospital of Dalian Medical University, Dalian 116100, P. R. China.

Wei Xu (W)

Department of Head & Neck Surgery, Shandong Provincial ENT Hospital Affiliated to Shandong University, Jinan 250022, P. R. China; Shandong Provincial Institute of Otolaryngology, Jinan 250022, P. R. China; Key Laboratory of Otolaryngology, Ministry of Health, Shandong University, Jinan 250022, P. R. China. Electronic address: xuwhns@126.com.

Wei Gao (W)

Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China; Shanxi Province Clinical Medical Research Center for Precision Medicine of Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China; Department of Otolaryngology Head & Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China; Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, P. R. China. Electronic address: gaoweisxent@sxent.org.

Classifications MeSH